Aspirin And Extended-release Dipyridamole Capsule
Product Images NDC 42291-116

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aspirin And Extended-release Dipyridamole (NDC 42291-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 200 (116 60 25mg 200mg)

Label for Aspirin and Extended-Release Dipyridamole Capsules 25 mg / 200 mg in a unit-of-use container with 60 capsules. The label includes dosage form as capsules, oral route, Rx only designation, storage instructions, and manufacturer information for AvKARE and Amneal Pharmaceuticals. Barcode and NDC 42291-116-60 are visible.*

FDA Label Image

Chem Struc Dp (Aspirin And Extended Release Dipyridamole Capsules 1)

Chemical structure of the active ingredient shown, labeled with molecular formula C24H40N8O4 and molecular weight 504.63, representing the detailed molecular arrangement of the compound.*

FDA Label Image

Chem Struc Asp (Aspirin And Extended Release Dipyridamole Capsules 2)

Chemical structure of Aspirin showing the molecular formula C9H8O4 and molecular weight 180.16. The diagram includes labeled functional groups such as carboxyl and ester groups attached to a benzene ring.*

FDA Label Image

Figure 1 (Aspirin And Extended Release Dipyridamole Capsules 3)

A line graph showing cumulative stroke rate (%) over 24 months of follow-up for three treatment groups: Aspirin and Extended-Release Dipyridamole, aspirin (ASA), and placebo. The vertical axis represents stroke rate percentage from 0 to 20%, and the horizontal axis shows months from 0 to 24. The graph includes a legend identifying symbols for each group and a note explaining dosages: extended-release dipyridamole 200 mg and aspirin 25 mg, with all dosages given twice daily (b.i.d.).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.